Skip to main navigation
Viridian Theraputics

ENGINEERING MEDICINES TO IMPROVE PATIENT CARE

Menu
  • About Viridian
    • Leadership
    • Board of Directors
  • Pipeline
    • Approach
    • History of IGF1R
  • Patients
    • About TED
    • Clinical Trials
  • Careers
  • Investors
    • Press Releases
    • Events & Presentations
      • Scientific Presentations
    • Filings
    • Analyst Coverage
    • Corporate Governance
      • Governance Documents
      • Leadership
      • Board of Directors
      • Committee Composition
    • Investor Resources
    • Email Alerts
  • Contact

ENGINEERING MEDICINES TO IMPROVE PATIENT CARE

Investors

Event Details

Viridian Therapeutics VRDN-001 Clinical Update & Second Quarter 2022 Earnings Call

August 15, 2022 8:00 AM EDT
Listen to Webcast

Supporting Materials

VRDN-001 initial clinical data – August 2022 1.9 MB
Viridian Theraputics

Copyright© 2023 Viridian Therapeutics Inc. All Rights Reserved

Terms of Use Privacy Policy Careers